Prognostic Value of BIM Deletion in EGFR-Mutant NSCLC Patients Treated with EGFR-TKIs: A Meta-Analysis

Figure 5

Forest plot of BIM deletion polymorphism associated with disease control rate in EGFR-mutant NSCLC patients treated with EGFR-TKIs.